Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Comparacin con otros agonistas GLP-1 Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta) Lixisenatide (Lyxumia) Semaglutide (Ozempic y Wegovy) Comparaciones especficas Cul elegir
The integration of glucagon-mediated energy expenditure with the appetite-suppressive and insulinotropic effects of GIP and GLP-1 agonism is hypothesized to explain the substantial weight loss and metabolic improvements observed in Phase 2 trials
Semaglutide and type 2 diabetes Semaglutide helps lower blood sugar in adults with type 2 diabetes
Semaglutide is primarily approved for managing obesity and weight-related health conditions, but it may also be considered for individuals experiencing medically significant weight gain due to other factors, such as medication side effects
Sources: Healthline
